Research shows that exercise is essential for protecting your heart after weight loss, while the medication liraglutide alone does not provide these benefits. In a 2026 study of 130 adults, those who exercised regularly reduced blood vessel damage and inflammation markers by significant amounts, whether or not they also took liraglutide. Combining exercise with the medication produced the best results, but exercise was the critical ingredient in all successful outcomes.
A new study shows that exercise is the real winner when it comes to protecting your heart after weight loss. Researchers followed 130 adults with obesity who lost weight through dieting, then tested what happened when they either exercised, took a medication called liraglutide, or did both for a year. The results were clear: people who exercised—whether alone or combined with the medication—had healthier blood vessels and less inflammation in their bodies. The medication alone didn’t provide these heart-protecting benefits. According to Gram Research analysis, this finding emphasizes that staying active is crucial for keeping your cardiovascular system healthy, even after successfully losing weight.
Key Statistics
A 2026 randomized controlled trial of 130 adults with obesity found that exercise reduced carotid intima-media thickness and systemic inflammation markers (interleukin-6 and interferon-gamma), while liraglutide medication alone showed no improvements in vascular health.
According to research reviewed by Gram, the combination of exercise plus liraglutide improved three key endothelial function markers (sICAM-1, sVCAM-1, and tPA) in 130 adults during a 52-week weight maintenance period, but exercise alone was sufficient to reduce blood vessel damage.
In a 2026 study published in Nature Metabolism, 130 adults who exercised regularly after weight loss showed significant reductions in pro-inflammatory cytokine levels, while those taking liraglutide without exercise experienced no such improvements.
The Quick Take
- What they studied: Whether exercise and/or a weight-loss medication called liraglutide could improve heart and blood vessel health in people who had lost weight
- Who participated: 130 adults with obesity who completed a weight-loss diet program, then were randomly assigned to different maintenance groups for one year
- Key finding: Exercise reduced markers of blood vessel damage and body inflammation, while the medication alone did not provide these protective benefits
- What it means for you: If you’ve lost weight, staying physically active is more important for protecting your heart than relying on medication alone. This doesn’t mean medication is bad—it just means exercise is the key ingredient for vascular health.
The Research Details
This was a carefully controlled experiment where researchers first had all 130 participants lose weight through diet. Then they randomly divided people into four groups: one that exercised regularly, one that took liraglutide (a medication that helps with weight loss), one that did both, and one that did neither. The researchers tracked everyone for 52 weeks, measuring changes in their blood vessels and inflammation levels using medical tests.
The study measured several important markers of heart health. They looked at the thickness of the carotid artery (a major blood vessel in your neck) using ultrasound, checked inflammation chemicals in the blood, and tested how well blood vessels could expand and contract properly. These measurements help doctors understand if someone’s cardiovascular system is getting healthier or sicker.
This type of study design—where people are randomly assigned to different treatments—is considered very reliable because it reduces bias and helps researchers understand cause-and-effect relationships.
Understanding what actually protects your heart after weight loss is crucial because many people regain weight or develop heart problems even after successful dieting. This research helps separate what really works (exercise) from what might seem helpful but doesn’t deliver the same cardiovascular benefits (medication alone). The findings guide both patients and doctors in making better decisions about weight maintenance strategies.
This study has several strengths: it was published in a top-tier scientific journal (Nature Metabolism), used objective medical measurements rather than just asking people how they felt, and tracked participants for a full year. The main limitation is the relatively small sample size of 130 people, which means results may not apply equally to everyone. Additionally, the study only measured short-term changes over one year, so we don’t know if benefits persist longer.
What the Results Show
The most striking finding was that exercise—whether done alone or combined with liraglutide—significantly reduced carotid intima-media thickness, which is a measure of blood vessel wall damage. Think of this like preventing rust from building up on pipes: thinner vessel walls mean healthier blood flow and lower heart disease risk.
Exercise also dramatically reduced two key inflammation markers in the blood: interleukin-6 and interferon-gamma. These are chemical messengers that signal inflammation throughout your body. When people exercised regularly, these inflammation markers dropped substantially, which is important because chronic inflammation is linked to heart disease, diabetes, and other serious conditions.
When people combined exercise with liraglutide, they got additional benefits. The combination improved three specific markers of endothelial function (the health of the inner lining of blood vessels): sICAM-1, sVCAM-1, and tPA. These improvements suggest that the combination treatment helps blood vessels work more efficiently and reduces clot formation risk.
Interestingly, liraglutide alone—without exercise—showed no improvements in any of these vascular health markers. This was surprising to researchers and suggests that the medication’s weight-loss benefits don’t automatically translate to heart protection.
The study found that the combination of exercise plus medication produced the most comprehensive improvements across multiple measures of vascular health. This suggests that when people can do both, they get the best results. However, the key takeaway is that exercise was the essential ingredient in all successful outcomes—it was never the medication alone that worked.
Previous research has shown that obesity damages blood vessels and increases inflammation, but this study provides clearer evidence about what specifically reverses that damage during weight maintenance. Earlier studies suggested that GLP-1 medications like liraglutide might improve heart health, but this research shows that benefit only appears when combined with exercise. The findings align with decades of exercise research showing that physical activity is one of the most powerful tools for cardiovascular protection.
The study included only 130 people, which is relatively small for drawing broad conclusions. The participants were followed for only one year, so we don’t know if benefits continue or fade over longer periods. The study didn’t track whether people actually maintained their weight loss or continued exercising after the study ended. Additionally, the research focused on specific biomarkers rather than actual heart attack or stroke rates, so we can’t say definitively that these improvements prevent real cardiovascular events. Finally, the study population may not represent all adults with obesity, as participants were selected for a clinical trial and may have been more motivated than average.
The Bottom Line
If you’ve lost weight, prioritize regular exercise as your primary strategy for protecting your heart. Aim for at least 150 minutes of moderate-intensity activity per week (like brisk walking) or 75 minutes of vigorous activity (like running). If your doctor recommends liraglutide or similar medications for weight maintenance, combining them with exercise provides additional benefits. These recommendations are supported by strong evidence from this controlled trial.
Anyone who has lost weight and wants to keep their heart healthy should pay attention to this research. People with obesity or a family history of heart disease should especially consider these findings. However, this study doesn’t mean people shouldn’t take liraglutide if prescribed—it just means exercise should be the foundation of any weight maintenance plan. People with physical limitations should talk to their doctor about what types of activity are safe for them.
You may notice improvements in inflammation markers within 2-4 weeks of starting regular exercise, but significant changes in blood vessel health typically take 8-12 weeks. The full benefits shown in this study emerged over the 52-week period, suggesting that consistency over months matters more than intensity.
Frequently Asked Questions
Does liraglutide protect your heart after weight loss?
Liraglutide alone did not improve heart health markers in this study. However, when combined with regular exercise, it enhanced vascular function. Exercise was the essential ingredient for cardiovascular protection in all successful outcomes.
How much exercise do you need to improve blood vessel health?
The study involved regular exercise over 52 weeks but didn’t specify exact amounts. Standard recommendations suggest 150 minutes of moderate-intensity activity weekly. Benefits in inflammation markers may appear within weeks, while blood vessel improvements typically take 8-12 weeks.
Can you maintain weight loss without exercise?
This study focused on vascular health rather than weight maintenance itself. However, the findings suggest that even if you maintain weight without exercise, your heart health may suffer. Exercise provides cardiovascular protection independent of weight changes.
What inflammation markers improve with exercise after weight loss?
Exercise reduced interleukin-6 and interferon-gamma, two key inflammation chemicals linked to heart disease. These reductions appeared in people who exercised regularly, whether or not they took liraglutide medication.
Is medication enough to protect your heart after losing weight?
This study shows medication alone is not sufficient for vascular protection. Exercise was necessary to reduce blood vessel damage and inflammation. Combining medication with exercise provided the most comprehensive cardiovascular benefits.
Want to Apply This Research?
- Log weekly exercise minutes and track a simple inflammation proxy like resting heart rate (lower is better) or energy levels. Set a goal of 150 minutes of moderate activity per week and monitor consistency rather than perfection.
- Start with 30 minutes of brisk walking five days per week. Use the app to set reminders, log completed sessions, and celebrate weekly milestones. If you’re on liraglutide or similar medication, log that too so you can see how combining both strategies affects your metrics over time.
- Track exercise adherence weekly, measure resting heart rate monthly, and assess energy levels and recovery. Every 3 months, review trends to see if consistent exercise is improving your baseline metrics. Share data with your doctor at annual checkups to monitor real cardiovascular health markers.
This research provides important insights into cardiovascular health during weight maintenance, but it should not replace personalized medical advice. Before starting any new exercise program or medication, consult with your healthcare provider, especially if you have existing heart conditions, diabetes, or other health concerns. The findings apply to the specific population studied and may not generalize to all individuals. Always discuss weight loss strategies and medications with your doctor to determine what’s appropriate for your individual health situation.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.